Chaperonin 10-induced immunomodulation

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Cbio Limited patent solves the following problem:

A central part of the host defense system against invading bacteria, fungal, yeast and viral pathogens involves the successful recognition of the pathogen, or components thereof, with the cellular receptor to induce a signaling cascade resulting in stimulation of the immune system and the production of various cytokines. A family of receptor that plays a key role in this line of defense is the Toll-like receptor (TLR) family. TLRs expressed in immune cells, including monocytes, macrophages, dendritic cells, B cells and granulocytes, and a variety of other types of cells including the endothelium and epithelium. TLR activation of pathogens, or by molecules derived thereof, accelerate the formulation intracellular signaling primarily the result of activation of transcription factor NF-B (begging, 2002, Trends Immunol 23 :. 509-12) and modulation cytokine production. . However, a series of other paths can also cause, including the P38 mitogen activated kinase, c-Jun N-terminal kinase and extracellular signal-related kinase pathway (Flohe et al, 2003, J Immunol 170: 2340-2348; Triantafilou and Triantafilou, 2002, Trends Immunol 23: 301-304).

Our analysis of this patent is as follows:

Cbio Limited’s patent US 9457062 B2 deals with Chaperonin 10-induced immunomodulation.
The present invention relates to methods for modulating Toll-like receptor signaling in a subject, or at least one cell, tissue or organ thereof, methods for treating or preventing a disease or state in a subject, methods for modulating the production and / or secretion of one or more immunomodulators in a subject, or at least one cell, tissue or organ thereof, wherein said method includes the administration chaperonin 10, and wherein the chaperonin 10 with a Toll-like receptor activation in a cluster. Also thought related compositions and uses thereof.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Systems and methods for UAV docking

File for Quick & Easy Patent Protection with PowerPatent.

The SZ DJI Technology Co., Ltd patent solves the following problem:

Aerial vehicles like unmanned aerial vehicles (UAVs) can be used to do surveillance, reconnaissance and exploration work for military and civilian applications. The aerial vehicles can carry a payload configured to perform a specific function.

Our analysis of this patent is as follows:

SZ DJI Technology Co., Ltd’s patent US 9457915 B2 deals with Systems and methods for UAV docking.
Systems and methods are provided for the docking of an unmanned aerial vehicle (UAV) with a car. UAV is able to recognize a company car from other vehicles in the area and vice versa. UAV may remove and / or in the car. UAV can be used to capture images and streams live images to a display inside the vehicle. cars can control the UAV. UAV can communicate with fellow car while fleeing.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

System, method, and computer program product for input/output buffer modeling

Be the First-to-File and Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Cadence Design Systems, Inc. patent solves the following problem:

Our analysis of this patent is as follows:

Cadence Design Systems, Inc.’s patent US 9460250 B1 deals with System, method, and computer program product for input/output buffer modeling.
The present disclosure relates to a computer-implemented method for transient simulation of an input / output buffer models. methods may include the creation of an input / output buffer data file associated with a first model of an electrical circuit. method may also include determining at least one of a node voltage and a current branches associated with the electrical circuit in use, at least in part, a way latency insertion, the method may further include performing one or more simulations at a second model of an electrical circuit, one or more superstitious use, at least in part, the input / output buffer data file and the latency insertion method.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Facet fixation device

Be the First-to-File and Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Spinesmith Partners, L.P. patent solves the following problem:

The human lumbar spine includes individual frame connected to one another by one of three joint complexthe vertebral disc and two joints. Under normal circumstances these structures act to protect nerve structures and allow us to stand upright, carrying the axial load, and flexible in bending and rotation. When a spinal cord disorder occurs due to disease or trauma, one or more of these backbone structures can not act normal, resulting in pain. In these pathologic conditions, surgery is needed to stabilize the spine, protect nerve structures, and relieve patient discomfort. Spine fusion works well because it stops the pain of movement of joints and intervertebral discs, hold the spine in place after the correction of deformity, and prevent instability and or defects theme by way theme as discectomies, or laminectomies corpectomies.

Our analysis of this patent is as follows:

Spinesmith Partners, L.P.’s patent US 9456904 B2 deals with Facet fixation device.
invention showed an implant assembly for on the one hand joint including an implant with a U-shaped body. The U-shaped body has a rounded front end, an open back end, the first and second elongated members extending from the rounded front end, building on the U-shaped body and after the open back end and a helical structure that came into the U-shaped body which serves as a locking mechanism.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Motor vehicle inspection device and method for identifying motor vehicles

File for Quick & Easy Patent Protection with PowerPatent.

The Robert Bosch Gmbh patent solves the following problem:

Unexamined patent application DE 199 42 844 A1 describes a system for the identification of the vehicle during the inspection of a test lane.

Our analysis of this patent is as follows:

Robert Bosch Gmbh’s patent US 9460132 B2 deals with Motor vehicle inspection device and method for identifying motor vehicles.
A method for identifying a motor vehicle for a plurality of devices that motor vehicle inspection, including the knowledge of a race car character; to determine basic data on their vehicles; hide quirks and the basic identification data of an identification data for this car to a storage medium; recognition to the knowledge of the data set associated with the vehicle storage medium based on a different character with a first plurality of motor vehicles dodge inspection; reading the data known to them to put the car out of storage medium; to determine the first data to identify vehicles, which are specific to the first plurality of motor vehicles dodge inspection; increase the read-out of the identification data set in the first data to them; storing more data to identify the storage medium; recognition to the knowledge of the data set associated with the vehicle storage medium based on a different character with a second plurality of motor vehicles dodge inspection; reading the data known to them to put the car out of storage medium; to determine the second data identifying the vehicles, which are specific for the second plurality of motor vehicles dodge inspection; increase the read-out of data identification placed second data to them; and gather further data to identify the storage medium.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Device for selectively reducing absorption of unhealthy food

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Medibotics Llc patent solves the following problem:

Our analysis of this patent is as follows:

Medibotics Llc’s patent US 9456916 B2 deals with Device for selectively reducing absorption of unhealthy food.
This creation is a device and method for selectively and automatically reduced absorption of bad food in the gastrointestinal tract of a human, while allowing the normal absorption of healthy food. In one example, as a device comprising: a meat-recognition sensor; an absorption-reducing substance; an implanted reservoir; and a release-to-own mechanism that selectively and automatically News the substance into the human gastrointestinal tract when the sensor detects that the people consuming unhealthy food.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Modified gram positive bacteria and uses thereof

Be the First-to-File and Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Intrexon Actobiotics Nv patent solves the following problem:

Program-positive bacteria collectively classified as a single lipid bilayer plasma membrane. Positive bacteria program includes a multitude of bacilliform and cocciform bacterial species, among which Bifidobacteria and a group of species collectively known as lactic acid bacteria (LAB). Lab consists of a Glade of gram-positive, low-GC, acid-tolerant, generally non-sporulating, non-respiring rod or cocci that are associated by their common metabolic and physiological characteristics. These bacteria, usually found in the (decomposing) plants and dairy products, lactic acid as the major metabolic end-products of carbohydrate fermentation. This character, throughout history, lab involved with food fermentations as acidification inhibits the growth of spoilage agents. A prototype Lab Lactococcus lactis is a mesophilic microaerophilic fermenting lactic acid bacteria. While the bacteria are widely used in food fermentations, especially in the dairy industry, there is an increasing interest for use in medicines and nutraceuticals, as medicine to treat infections of bodily hole as vaginal infections, or as a carrier for the delivery of biological active molecules. In all cases, there is a need for very viable starter culture, or drug or nutraceutical formulation containing a high number of viable bacteria. L. lactis, however, tends to lose viability during storage, or during processing (for ao the production of a dry powder formulation, tablet formation, …). The drop in viability more punishment when the bacteria after LYOPHILISATION submitted further pressure as high acidity or the presence of bile salts.

Our analysis of this patent is as follows:

Intrexon Actobiotics Nv’s patent US 9458467 B2 deals with Modified gram positive bacteria and uses thereof.
The present invention relates to a program positive bacteria, preferably in a lactic acid bacteria (LAB) or Bifidobacterium, with more stress resistance and / or improved manufacturing, processing and / or storage character. In particular, the invention relates to a program positive bacteria accumulate intracellular trehalose. The program positive bacteria according to the invention lacking trehalose 6-phosphate phosphorylase (TrePP) activity. The program positive bacteria becomes more than cellobiose-specific PTS system IIC component (PTCC) activity. The program positive bacteria may further overexpress trehalose transporters. invention further relates to compositions comprising the program positive bacteria as well as methods and uses thereof.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Recombinant proteins that simultaneously bind HGF, VEGF-A and serum albumin, comprising ankyrin repeat domains

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Molecular Partners Ag patent solves the following problem:

The following discussion of the background is only provided to assist readers in understanding the invention and is not admitted to describe or constitute prior art to the present invention.

Our analysis of this patent is as follows:

Molecular Partners Ag’s patent US 9458211 B1 deals with Recombinant proteins that simultaneously bind HGF, VEGF-A and serum albumin, comprising ankyrin repeat domains.
Bag-ong designed ankyrin repeat domains with binding specificity for serum albumin, artificial binding protein that contains at least two designed ankyrin repeat domains with binding specificity for serum albumin, as well as artificial binding protein that contains the at least a designed ankyrin repeat domains with binding specificity for hepatocyte growth factor (HGF), at least a designed ankyrin repeat domains with binding specificity for vascular endothelial growth that (VEGF-A), and at least two designed ankyrin repeat domains with binding specificity for serum albumin described, as well as nucleic acid encoding the designed ankyrin repeat domains and artificial binding proteins, pharmaceutical compositions containing the designed ankyrin repeat domains, artificial binding protein or nucleic acid and to use those designed ankyrin repeat domains, artificial binding protein, nucleic acid composition or medicine to treat the disease.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Methods and devices for spinal correction

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The DePuy Synthes Products, Inc. patent solves the following problem:

The human spine is a series of strong vertebral bodies separated by flexible plates called intervertebral discs. The plate consists of a compressible, flexible jelly-like center called the nucleus pulposus. FLEXIBILITY This allows the spine to bend and twist. The annulus fibrosus is a strong, fibrous material around and up the center, which can be extruded into other parts of the body.

Our analysis of this patent is as follows:

DePuy Synthes Products, Inc.’s patent US 9456817 B2 deals with Methods and devices for spinal correction.
An expandable test may include a lower, a greater portion, and a middle expansion phase as well as load cells to monitor the load test. Tests may also include recesses on the lateral side of the give-and to accommodate a disc tissue removal device to be cleared monitoring load. Furthermore, nerve foramen and may monitor to provide information about how many nerves release achieved as the disc cleaned and spine position and repositioned.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Dual function fibroblast growth factor 21 proteins

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Novartis Ag patent solves the following problem:

The fibroblast growth factor (FGF) family described in 22 genetically different, homologous ligands, which are grouped into seven subfamilies. FGF-21 is the closest related to, and form a family with, FGF-19 and FGF-23. This FGF family regulates various physiological processes common to classical FGFs, that strength and bile acid homeostasis, glucose and lipid metabolism, and phosphate as well as vitamin D homeostasis. Moreover, unlike other FGFs, this family works in an endocrine manner (Moore, DD (2007) Science 316, 1436-8) (Beenken et al. (2009) Nature Reviews Drug Discovery 8 , 235).

Our analysis of this patent is as follows:

Novartis Ag’s patent US 9458214 B2 deals with Dual function fibroblast growth factor 21 proteins.
The present invention relates to two protein function substitutes containing fibroblast growth factor 21 (FGF21) and exenatide, Exendin-4, or GLP-1. also disclosed methods for treating FGF21-associated disorder, GLP-1-associated diseases, and Exendin-4-associated disorders, including metabolic conditions.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.